首页> 外文期刊>応用薬理 >Selectivity of Valsartan to the Human Angiotensin II Type One Receptors as Assessed by Binding Affinity, Functional Activity and Molecular Modeling
【24h】

Selectivity of Valsartan to the Human Angiotensin II Type One Receptors as Assessed by Binding Affinity, Functional Activity and Molecular Modeling

机译:通过结合亲和力,功能活性和分子模拟评估,缬沙坦对人血管紧张素II的选择性。

获取原文
获取原文并翻译 | 示例
           

摘要

Investigations were done to establish the precise selectivity of valsartan to the human angiotensin II type 1 receptors. We have first evaluated the binding affinities and functional activities of valsartan to the angiotensin II receptor subtypes and compared these activities with those of other angiotensin II receptor blockers, such as candesartan, losartan, and telmisartan. Molecular modeling studies have been done to acquire more receptor specific ligand-receptor interactions. Site-directed mutagenesis has also been done as predicted by the molecular modeling of valsartan to AT_1 receptor to identify the important binding sites of valsartan to AT_1 receptors and we, therefore, confirmed the precise selectivity of this drag towards AT_1 receptor. We have also showed the inverse agonist activity of valsartan to the constitutively active mutant of AT_1 receptor and receptor internalization in presence of valsartan.
机译:进行研究以确定缬沙坦对人血管紧张素II型1受体的精确选择性。 我们首先评估了缬沙坦对血管紧张素II受体亚型的结合亲和力和功能活性,并将这些活性与其他血管素II受体阻滞剂的活动进行了比较,例如Candaartan,洛萨沙坦和Telmisartan。 已经进行了分子建模研究以获得更多受体特异性配体 - 受体相互作用。 除了通过缬沙坦至AT_1受体的分子建模预测的定向诱变,以鉴定缬沙坦的重要结合位点至AT_1受体,因此,我们证实了这种阻力朝向AT_1受体的精确选择性。 我们还显示出Valsartan的逆激动剂活性至缬沙坦的AT_1受体的组成型活性突变体和受体内化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号